BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32514643)

  • 1. Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines.
    Kennedy-Martin M; Slaap B; Herdman M; van Reenen M; Kennedy-Martin T; Greiner W; Busschbach J; Boye KS
    Eur J Health Econ; 2020 Nov; 21(8):1245-1257. PubMed ID: 32514643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D Multi-Attribute Utility Instruments in Patients Who Have Previously Undergone Bariatric Surgery.
    Campbell JA; Palmer AJ; Venn A; Sharman M; Otahal P; Neil A
    Patient; 2016 Aug; 9(4):311-22. PubMed ID: 26841910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review of the Psychometric Performance of Generic Childhood Multi-attribute Utility Instruments.
    Kwon J; Smith S; Raghunandan R; Howell M; Huynh E; Kim S; Bentley T; Roberts N; Lancsar E; Howard K; Wong G; Craig J; Petrou S
    Appl Health Econ Health Policy; 2023 Jul; 21(4):559-584. PubMed ID: 37133712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models.
    Ahmad H; Campbell JA; van der Mei I; Taylor BV; Xia Q; Zhao T; Palmer AJ
    Qual Life Res; 2023 Dec; 32(12):3373-3387. PubMed ID: 37522942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey.
    Kularatna S; Senanayake S; Gunawardena N; Graves N
    BMJ Open; 2019 Feb; 9(2):e024854. PubMed ID: 30772857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease.
    Kularatna S; Byrnes J; Chan YK; Ski CF; Carrington M; Thompson D; Stewart S; Scuffham PA
    Qual Life Res; 2017 Dec; 26(12):3399-3408. PubMed ID: 28766084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the Sensitivity and Construct Validity of 6 Utility Instruments in 7 Disease Areas.
    Richardson J; Iezzi A; Khan MA; Chen G; Maxwell A
    Med Decis Making; 2016 Feb; 36(2):147-59. PubMed ID: 26582319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations.
    Chen G; Ratcliffe J
    Pharmacoeconomics; 2015 Oct; 33(10):1013-28. PubMed ID: 25985933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Outcomes for Cost-Utility Analysis in Children and Adolescents With Mental Health Problems: Are Multiattribute Utility Instruments Fit for Purpose?
    Mihalopoulos C; Chen G; Scott JG; Bucholc J; Allen C; Coghill D; Jenkins P; Norman R; Ratcliffe J; Richardson J; Stathis S; Viney R
    Value Health; 2023 May; 26(5):733-741. PubMed ID: 36535579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments.
    Richardson J; Khan MA; Iezzi A; Maxwell A
    Med Decis Making; 2015 Apr; 35(3):276-91. PubMed ID: 25159172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Exploratory Study: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D for Long-Term Publicly Waitlisted Bariatric Surgery Patients Before and 3 Months After Bariatric Surgery.
    Campbell JA; Hensher M; Neil A; Venn A; Otahal P; Wilkinson S; Palmer AJ
    Pharmacoecon Open; 2018 Dec; 2(4):443-458. PubMed ID: 29623636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing multi-attribute utility instruments: CP-6D, a Cerebral palsy specific instrument, vs AQoL-4D.
    Bahrampour M; Downes M; Scuffham PA; Byrnes J
    Expert Rev Pharmacoecon Outcomes Res; 2022 Mar; 22(2):217-224. PubMed ID: 33779449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic literature review of health state utility values in head and neck cancer.
    Meregaglia M; Cairns J
    Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures.
    Mihalopoulos C; Chen G; Iezzi A; Khan MA; Richardson J
    Br J Psychiatry; 2014 Nov; 205(5):390-7. PubMed ID: 25257063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of depression on health-related quality of life and wellbeing: identifying important dimensions and assessing their inclusion in multi-attribute utility instruments.
    Engel L; Chen G; Richardson J; Mihalopoulos C
    Qual Life Res; 2018 Nov; 27(11):2873-2884. PubMed ID: 30006664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can multi-attribute utility instruments adequately account for subjective well-being?
    Richardson J; Chen G; Khan MA; Iezzi A
    Med Decis Making; 2015 Apr; 35(3):292-304. PubMed ID: 25623064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of preference-based health-related quality of life questionnaires in spinal cord injury research.
    Whitehurst DG; Noonan VK; Dvorak MF; Bryan S
    Spinal Cord; 2012 Sep; 50(9):646-54. PubMed ID: 22641255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of the Methods Used to Generate Utility Values in NICE Technology Assessments for Children and Adolescents.
    Hill H; Rowen D; Pennington B; Wong R; Wailoo A
    Value Health; 2020 Jul; 23(7):907-917. PubMed ID: 32762993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the Functional Independence Measure to a multi-attribute utility instrument for economic evaluations in rehabilitation: a secondary analysis of randomized controlled trial data.
    Peiris CL; Taylor NF; Watts JJ; Shields N; Brusco NK; Mortimer D
    Disabil Rehabil; 2020 Oct; 42(21):3024-3032. PubMed ID: 30907143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.